Ocugen, Inc. (OCGN) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1232377,
    "name": "Ocugen, Inc.",
    "stock_name": "Ocugen, Inc.",
    "full_name": "Ocugen, Inc.",
    "name_url": "stocks-analysis/ocugen-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "1.24",
    "chg": 0.08,
    "chgp": "6.9%",
    "dir": 1,
    "prev_price": "1.16",
    "mcapval": "321.80",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US67577C1053",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "6.56 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ocugen-inc-1232377-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Ocugen, Inc. Hits New 52-Week High of $1.90, Marking Major Milestone",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ocugen-inc-hits-new-52-week-high-of-190-marking-major-milestone-3595683",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/OcugenInc_priceRelatedfactors_3595683.png",
        "date": "2025-10-06 17:42:41",
        "description": "Ocugen, Inc. has achieved a new 52-week high of USD 1.90, significantly up from its low of USD 0.52, reflecting a year-over-year performance of 14.19%. The company, with a market cap of USD 322 million, faces challenges such as a negative return on equity and a high price-to-book ratio."
      },
      {
        "title": "Ocugen, Inc. Hits New 52-Week High at $1.78, Marking Significant Milestone",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ocugen-inc-hits-new-52-week-high-at-178-marking-significant-milestone-3571366",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/OcugenInc_priceRelatedfactors_3571366.png",
        "date": "2025-09-25 16:50:47",
        "description": "Ocugen, Inc. has achieved a new 52-week high of USD 1.78, significantly up from its low of USD 0.52. Despite this milestone, the company's one-year performance lags behind the S&P 500. With a market cap of USD 322 million, Ocugen remains in a loss-making position amid industry competition."
      },
      {
        "title": "Ocugen, Inc. Hits New 52-Week High of $1.69, Marking Significant Milestone",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ocugen-inc-hits-new-52-week-high-of-169-marking-significant-milestone-3565362",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/OcugenInc_priceRelatedfactors_3565362.png",
        "date": "2025-09-24 13:39:46",
        "description": "Ocugen, Inc. has achieved a new 52-week high of USD 1.69, significantly up from its low of USD 0.52. Despite this milestone, the company's 1-year performance lags behind the S&P 500. Ocugen, with a market cap of USD 322 million, remains loss-making and does not offer dividends."
      },
      {
        "title": "Is Ocugen, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-ocugen-inc-technically-bullish-or-bearish-3548087",
        "imagepath": "",
        "date": "2025-09-20 20:09:25",
        "description": "As of 1 August 2025, the technical trend for Ocugen, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. Bollinger Bands indicate a bullish stance for both weekly and monthly periods. Daily moving averages are also bullish. However, the KST shows a mildly bearish signal on both weekly and monthly time frames, and the OBV is mildly bullish weekly but mildly bearish monthly. Dow Theory supports a mildly bullish outlook for both weekly and monthly periods. \n\nIn terms of performance, Ocugen has significantly outperformed the S&P 500 with a year-to-date return of 73.91% compared to the S&P 500's 12.22%. Overall, the current technical stance is mildly bullish, driven by strong short-term momentum and positive indicators, despite some mixed signals in longer-term metrics...."
      },
      {
        "title": "Is Ocugen, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-ocugen-inc-overvalued-or-undervalued-3544246",
        "imagepath": "",
        "date": "2025-09-20 18:41:34",
        "description": "As of 9 February 2024, the valuation grade for Ocugen, Inc. has moved from does not qualify to risky, indicating a heightened level of concern regarding its financial health. The company appears to be overvalued given its significant negative ratios, including a Price to Book Value of 19.46, an EV to EBIT of -5.26, and an ROCE of -875.01%. In comparison to peers, Esperion Therapeutics, Inc. has a P/E of -4.9940, while Protalix Biotherapeutics, Inc. is considered attractive with a P/E of 20.0760, highlighting Ocugen's relative underperformance.\n\nDespite recent stock performance showing a 73.91% year-to-date return compared to the S&P 500's 12.22%, the underlying financial metrics suggest that Ocugen's valuation is not supported by its earnings or operational efficiency, reinforcing the conclusion that it is overvalued...."
      },
      {
        "title": "Ocugen, Inc. Hits New 52-Week High of $1.48, Signaling Strong Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ocugen-inc-hits-new-52-week-high-of-148-signaling-strong-momentum-3537165",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/OcugenInc_priceRelatedfactors_3537165.png",
        "date": "2025-09-19 13:13:58",
        "description": "Ocugen, Inc. has achieved a new 52-week high of USD 1.48, rebounding from a low of USD 0.52. Despite this recent gain, the company has experienced a one-year decline of 9.68%. With a market cap of USD 322 million, Ocugen remains in a challenging financial position."
      },
      {
        "title": "Ocugen, Inc. Hits New 52-Week High of $1.32, Marking Significant Milestone",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ocugen-inc-hits-new-52-week-high-of-132-marking-significant-milestone-3531561",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/OcugenInc_priceRelatedfactors_3531561.png",
        "date": "2025-09-18 13:26:08",
        "description": "Ocugen, Inc. has achieved a new 52-week high of USD 1.32, contrasting with its low of USD 0.52. Despite this milestone, the company's one-year performance is down 14.84%. With a market cap of USD 322 million, Ocugen remains in a loss-making position amid a competitive industry landscape."
      }
    ],
    "total": 12,
    "sid": "1232377",
    "stock_news_url": "https://www.marketsmojo.com/news/ocugen-inc-1232377"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Ocugen, Inc. Hits New 52-Week High of $1.90, Marking Major Milestone

2025-10-06 17:42:41

Ocugen, Inc. has achieved a new 52-week high of USD 1.90, significantly up from its low of USD 0.52, reflecting a year-over-year performance of 14.19%. The company, with a market cap of USD 322 million, faces challenges such as a negative return on equity and a high price-to-book ratio.

Ocugen, Inc. Hits New 52-Week High at $1.78, Marking Significant Milestone

2025-09-25 16:50:47

Ocugen, Inc. has achieved a new 52-week high of USD 1.78, significantly up from its low of USD 0.52. Despite this milestone, the company's one-year performance lags behind the S&P 500. With a market cap of USD 322 million, Ocugen remains in a loss-making position amid industry competition.

Ocugen, Inc. Hits New 52-Week High of $1.69, Marking Significant Milestone

2025-09-24 13:39:46

Ocugen, Inc. has achieved a new 52-week high of USD 1.69, significantly up from its low of USD 0.52. Despite this milestone, the company's 1-year performance lags behind the S&P 500. Ocugen, with a market cap of USD 322 million, remains loss-making and does not offer dividends.

Is Ocugen, Inc. technically bullish or bearish?

2025-09-20 20:09:25

As of 1 August 2025, the technical trend for Ocugen, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. Bollinger Bands indicate a bullish stance for both weekly and monthly periods. Daily moving averages are also bullish. However, the KST shows a mildly bearish signal on both weekly and monthly time frames, and the OBV is mildly bullish weekly but mildly bearish monthly. Dow Theory supports a mildly bullish outlook for both weekly and monthly periods. In terms of performance, Ocugen has significantly outperformed the S&P 500 with a year-to-date return of 73.91% compared to the S&P 500's 12.22%. Overall, the current technical stance is mildly bullish, driven by strong short-term momentum and positive indicators, despite some mixed signals in longer-term metrics....

Is Ocugen, Inc. overvalued or undervalued?

2025-09-20 18:41:34

As of 9 February 2024, the valuation grade for Ocugen, Inc. has moved from does not qualify to risky, indicating a heightened level of concern regarding its financial health. The company appears to be overvalued given its significant negative ratios, including a Price to Book Value of 19.46, an EV to EBIT of -5.26, and an ROCE of -875.01%. In comparison to peers, Esperion Therapeutics, Inc. has a P/E of -4.9940, while Protalix Biotherapeutics, Inc. is considered attractive with a P/E of 20.0760, highlighting Ocugen's relative underperformance. Despite recent stock performance showing a 73.91% year-to-date return compared to the S&P 500's 12.22%, the underlying financial metrics suggest that Ocugen's valuation is not supported by its earnings or operational efficiency, reinforcing the conclusion that it is overvalued....

Ocugen, Inc. Hits New 52-Week High of $1.48, Signaling Strong Momentum

2025-09-19 13:13:58

Ocugen, Inc. has achieved a new 52-week high of USD 1.48, rebounding from a low of USD 0.52. Despite this recent gain, the company has experienced a one-year decline of 9.68%. With a market cap of USD 322 million, Ocugen remains in a challenging financial position.

Ocugen, Inc. Hits New 52-Week High of $1.32, Marking Significant Milestone

2025-09-18 13:26:08

Ocugen, Inc. has achieved a new 52-week high of USD 1.32, contrasting with its low of USD 0.52. Despite this milestone, the company's one-year performance is down 14.84%. With a market cap of USD 322 million, Ocugen remains in a loss-making position amid a competitive industry landscape.

View All News